TABLE 6.
Absence of virus in nervous tissue in BDV-infected rats treated with anti-gp94 neutralizing monoclonal antibody prior to infection
Viral component | Area found | Viral component presence in:
|
|
---|---|---|---|
Control rats | Antibody-treated ratsa | ||
Antigenb | Forebrain | +, +, + | |
Cerebellum | +, +, + | −, −, − | |
Thoracal spinal cord | +, +, + | −, −, − | |
Lumbar spinal cord | +, +, + | −, −, − | |
Nucleic acidc | Forebrain | +, +, + | −, −, − |
Cerebellum | +, +, + | −, −, − | |
Infectious virus (log10 virus titer) | Forebrain | 6.8, 4.6, 7.5 | <1.8, <1.8, <1.8 |
Cerebellum | 3.9, 3.6, 4.3 | <1.8, <1.8, <1.8 | |
Thoracal spinal cord | 5.3, 4.9, 4.9 | <1.8, <1.8, <1.8 | |
Lumbar spinal cord | 3.3, 3.9, 4.3 | <1.8, <1.8, <1.8 |
Treatment was given 3 days and 1 day prior to and every 7 days after BDV infection until day 28 p.i. Rats were killed on day 35 p.i.
Detected by Western blotting.
Detected by in situ hybridization.